Champions Oncology, Inc.: shareholders and insiders

CSBRNASDAQHealthcare · Biological Products, (No Diagnostic Substances)

Price

$4.59

November 17, 2026Market cap $64M

What Ploutos Investor adds for Champions Oncology

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 9 fiscal years, from FY2018
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 17, 2025 to Nov 9, 2026, from their own Form 4 filings.

5 Form 4s

Bought on the market

–

nobody

Sold on the market

–

nobody

From Nov 17, 2025 to Nov 17, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

  • Oct 15, 2026Joel AckermanDirector
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by CSBR's officers and directors from 2008 up to November 16, 2025, 18 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

0 Holders over 5%Feb 14, 2025 Latest filing

Nobody reports more than 5% today: those who filed have since fallen to 5% or less.

Fell to 5% or less (1)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Tocqueville Asset Management L.P.4.40%Feb 14, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter
  • Renaissance Technologies
    In the quarter-6.8%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 0.56% of its shares outstanding were held short, +9.4% since the report before.

Shares held short
77.7K
0.56%
Since the report before71.0K on Sep 30, 2026
+9.4%
9.4
8,271
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 72.9K
  • Nov 15, 2023: Shares held short 71.0K
  • Nov 30, 2023: Shares held short 69.8K
  • Dec 15, 2023: Shares held short 81.6K
  • Dec 29, 2023: Shares held short 67.9K
  • Jan 12, 2024: Shares held short 64.0K
  • Jan 31, 2024: Shares held short 67.9K
  • Feb 15, 2024: Shares held short 63.4K
  • Feb 29, 2024: Shares held short 64.5K
  • Mar 15, 2024: Shares held short 62.6K
  • Mar 28, 2024: Shares held short 58.1K
  • Apr 15, 2024: Shares held short 56.5K
  • Apr 30, 2024: Shares held short 59.6K
  • May 15, 2024: Shares held short 56.1K
  • May 31, 2024: Shares held short 53.2K
  • Jun 14, 2024: Shares held short 52.2K
  • Jun 28, 2024: Shares held short 49.6K
  • Jul 15, 2024: Shares held short 49.1K
  • Jul 31, 2024: Shares held short 48.4K
  • Aug 15, 2024: Shares held short 48.4K
  • Aug 30, 2024: Shares held short 50.0K
  • Sep 13, 2024: Shares held short 327.7K
  • Sep 30, 2024: Shares held short 217.7K
  • Oct 15, 2024: Shares held short 200.1K
  • Oct 31, 2024: Shares held short 189.5K
  • Nov 15, 2024: Shares held short 224.5K
  • Nov 29, 2024: Shares held short 217.9K
  • Dec 13, 2024: Shares held short 226.0K
  • Dec 31, 2024: Shares held short 176.4K
  • Jan 15, 2025: Shares held short 108.9K
  • Jan 31, 2025: Shares held short 104.3K
  • Feb 14, 2025: Shares held short 98.8K
  • Feb 28, 2025: Shares held short 115.7K
  • Mar 14, 2025: Shares held short 123.9K
  • Mar 31, 2025: Shares held short 156.5K
  • Apr 15, 2025: Shares held short 146.0K
  • Apr 30, 2025: Shares held short 149.7K
  • May 15, 2025: Shares held short 106.4K
  • May 30, 2025: Shares held short 95.3K
  • Jun 13, 2025: Shares held short 95.9K
  • Jun 30, 2025: Shares held short 109.2K
  • Jul 15, 2025: Shares held short 108.1K
  • Jul 31, 2025: Shares held short 105.7K
  • Aug 15, 2025: Shares held short 94.8K
  • Aug 29, 2025: Shares held short 86.3K
  • Sep 15, 2025: Shares held short 92.0K
  • Sep 30, 2025: Shares held short 88.3K
  • Oct 15, 2025: Shares held short 83.6K
  • Oct 31, 2025: Shares held short 83.4K
  • Nov 14, 2025: Shares held short 78.6K
  • Nov 28, 2025: Shares held short 76.6K
  • Dec 15, 2025: Shares held short 80.6K
  • Dec 31, 2025: Shares held short 77.4K
  • Jan 15, 2026: Shares held short 79.9K
  • Jan 30, 2026: Shares held short 76.4K
  • Feb 13, 2026: Shares held short 75.3K
  • Feb 27, 2026: Shares held short 69.6K
  • Mar 13, 2026: Shares held short 72.6K
  • Mar 31, 2026: Shares held short 81.9K
  • Apr 15, 2026: Shares held short 82.0K
  • Apr 30, 2026: Shares held short 83.7K
  • May 15, 2026: Shares held short 84.7K
  • May 29, 2026: Shares held short 80.6K
  • Jun 15, 2026: Shares held short 78.5K
  • Jun 30, 2026: Shares held short 76.9K
  • Jul 15, 2026: Shares held short 75.6K
  • Jul 31, 2026: Shares held short 76.2K
  • Aug 14, 2026: Shares held short 74.0K
  • Aug 31, 2026: Shares held short 74.3K
  • Sep 15, 2026: Shares held short 68.5K
  • Sep 30, 2026: Shares held short 71.0K
  • Oct 15, 2026: Shares held short 77.7K

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading42.2% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 42.2% of the shares in the reported trades were short sales, against 35.0% in the 14 before.

Last 14 sessionsOct 28, 2026 – Nov 16, 2026
42.2%
The 14 beforeOct 8, 2026 – Oct 27, 2026
35.0%
Change
+7.2 pts
Short sales a dayon average, of 4,189 shares
1,767
More than atof 3,668 US-listed companies, same days
25%
Median of alleight in ten from 34.7% to 63.8%
50.3%
  • Oct 8, 2026: Short sales 54.8%
  • Oct 9, 2026: Short sales 31.7%
  • Oct 12, 2026: Short sales 76.6%
  • Oct 13, 2026: Short sales 92.7%
  • Oct 14, 2026: Short sales 35.7%
  • Oct 15, 2026: Short sales 18.4%
  • Oct 16, 2026: Short sales 47.1%
  • Oct 19, 2026: Short sales 12.1%
  • Oct 20, 2026: Short sales 22.6%
  • Oct 21, 2026: Short sales 7.7%
  • Oct 22, 2026: Short sales 13.7%
  • Oct 23, 2026: Short sales 60.4%
  • Oct 26, 2026: Short sales 6.8%
  • Oct 27, 2026: Short sales 2.2%
  • Oct 28, 2026: Short sales 22%
  • Oct 29, 2026: Short sales 66.2%
  • Oct 30, 2026: Short sales 45%
  • Nov 2, 2026: Short sales 10.2%
  • Nov 3, 2026: Short sales 7.6%
  • Nov 4, 2026: Short sales 33.4%
  • Nov 5, 2026: Short sales 95.9%
  • Nov 6, 2026: Short sales 66.9%
  • Nov 9, 2026: Short sales 68.9%
  • Nov 10, 2026: Short sales 88.6%
  • Nov 11, 2026: Short sales 36.8%
  • Nov 12, 2026: Short sales 8.9%
  • Nov 13, 2026: Short sales 5.7%
  • Nov 16, 2026: Short sales 75.9%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

1.32M Insiders' shares9.54% Of the company
  • Joel AckermanDirector
    Directly1.13M
  • Daniel Newman MendelsonDirector
    Directly198.6K

A lower bound: it counts only the 2 officers and directors with a market trade since Nov 18, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 341 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

3 ETFs holding it0.01% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

3 of the 341 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

28 Managers, Q2 2026$36M Value of their positions
  • Q3 2025: Managers 27
  • Q4 2025: Managers 27
  • Q1 2026: Managers 25
  • Q2 2026: Managers 28

Institutional investors by quarter

The fund managers holding CSBR, quarter by quarter, from Q2 2013 to Q2 2025, 49 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 28 managers held 5.90M shares, worth $36M. During the quarter 4 opened a position, 1 closed one, 5 added and 7 trimmed.

The largest holders, Q2 2026

  • Battery Management
    In the quarter
  • NEA Management
    In the quarter
  • Vanguard Capital Management
    In the quarter+0.6%
  • Tocqueville Asset Management
    In the quarter-7.5%
  • Morgan Stanley
    In the quarter-2.8%
  • Bank of America
    In the quarter+880%
  • Renaissance Technologies
    In the quarter-4.5%
  • BlackRock
    In the quarter+4.8%
  • Mink Brook Asset Management
    In the quarter
  • Geode Capital Management
    In the quarter-1.1%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Champions Oncology's filings show?

Who buys and sells is one part of Champions Oncology's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about CSBR's shareholders

Didn't find what you were looking for?

Ask us
Have CSBR's insiders bought or sold?

From Oct 16, 2026 to Nov 9, 2026 Champions Oncology's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold CSBR?

2 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $600.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.